Response to hepatitis B vaccination in high risk population

Journal of Communicable Diseases

Volumn 32, Issue 1, 2000, Pages 17-21

  Prakash, Charu ^a   Bhatia, Rajesh ^a   Kumari, S ^a   Verghese, T ^a   Datta, K K ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENGERIX-B; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TIME; VACCINATION;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0034152513     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR, Feb 1990 ; 39 : RR-2 : 10-20.
2. Ambrosch, F., Frisch-Niggemeyer, W., Kremsner, P., et al. Persistence of vaccine induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects. Postgraduate Medical Journal. 1987 ; 63 (Suppl. 2) : 129-135.
3. Goudeau, A., Denis, F., Mounier, M. et al. Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers. Postgraduate Medical Journal. 1987 ; 63 (Suppl. 2) : 125-128.
4. Firsch-Niggemeyer, W., Ambrosch, F., and Hofmann, H., et al. The assesment of immunity against hepatitis B after vaccination. Jour. Biol. Standardization. 1986 : 14 : 255-258.
5. Goh, K.T., Oon, C.J., Heng, B.H., and Lim, G.K., et al. Long term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull Wld. Hth. Org. 1995 ; 73(4) : 523-527.
6. Sehgal, A., Pavri, K., Arankalle, V., et al. Antibody response to hepatitis B vaccine in medical and paramedical personnel In India. India. J. Med. Res. 1987; 85 : 231-234.
7. Ljunggren, K., Lofgren, B., and Nordenfelt, E. Varying antibody response in hospital staff vaccinated against hepatitis B. Scand J. Infect. Dis. 1988 ; 20 : 485-488.
8. Francis, D. P., Hadler, S.C., Thompson, S.E., et al. The prevention of the hepatitis B with vaccine. Report of the Centers for Disease Control multi-centre efficacy trial among homosexual men. Annals Internal medicine. 1982 ; 97 : 3 : 362-366.
9. Joshi, N., Rao, P.N., Dixit, V.K., et al. Immunization of hospital staff by recombinant hepatitis B vaccine. Indian J. Med. Micr. 1995 ; 13 : 41-44.
10. Mittal, S. K., Rao, S., et al. Simultaneous administration of hepatitis B vaccine with other EPI vaccines. Indian J. Pediatr. 1994 ; 61 : 183-188.
11. Piazza, M., Villari, R., Orlando, R., et al. Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet. 1985 ; 949-952.
12. Strickler, A. C, Kibsey, P.C., and Vellend, H. Seroconversion rates with hepatitis B vaccine. Ann. Intern. Med. 1984 ; 101 : 564.